The status quo and evolution of glycoconjugates for cancer immunotherapy. [PDF]
Glycoconj JSingh Y, Kamra M.
europepmc +1 more source
Total synthesis of the capsular polysaccharide repeating unit towards the development of a glycoconjugate vaccine against <i>Klebsiella pneumoniae</i> ST512. [PDF]
Beilstein J Org ChemZhang S, Daněk O, Seeberger PH.
europepmc +1 more source
Unlocking the Potency of Keyhole Limpet Hemocyanin: Structural Insights, Immunological Mechanisms, and Therapeutic Frontiers. [PDF]
Int J Mol SciCermakova P, Cehlar O, Piestansky J.
europepmc +1 more source
Recent developments in typhoidal and non-typhoidal Salmonella vaccines. [PDF]
Curr Opin Infect DisBlank M, Rydlova A, Gibani MM.
europepmc +1 more source
Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against <i>Haemophilus influenzae</i> type b. [PDF]
Sci AdvHan W +9 more
europepmc +1 more source
Development and evaluation of a dual target glycoconjugate vaccine against Shigella sonnei
Hall CL +6 more
europepmc +1 more source
Recent Advances in Lipopolysaccharide-Based Glycoconjugate Vaccines [PDF]
Expert Review of Vaccines, 2021 Introduction The public health burden caused by pathogenic Gram-negative bacteria is increasingly prominent due to antimicrobial resistance. The surface carbohydrates are potential antigens for vaccines against Gram-negative bacteria.
Andrew J. Pollard +2 more
exaly +2 more sources
Related searches:
Improving Protein Glycan Coupling Technology (PGCT) for Glycoconjugate Vaccine Production
Expert Review of Vaccines, 2020Timothy A Scott +2 more
exaly